NetworkNewsBreaks – Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) Featured in Mizuho Securities Research Report
Biohaven Pharmaceutical Holding Company (NYSE: BHVN) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “The prescription ramp for Nurtec ODT in acute migraine continues to beat our expectations, with weekly Symphony prescription volumes ahead of our forecasts. With 3Q20 coming to a close, we are updating our BHVN model to incorporate additional reported weekly Symphony data but also increasing our gross-to-net (‘GTN’) as we believe GTN will likely be under pressure in the near term but should improve over time. As a result, we are lowering our 3Q20 sales forecast from…







